E74-like factor inhibition induces reacquisition of hormone sensitiveness decreasing period circadian protein homolog 1 expression in prostate cancer cells

Prostate International

Volumn 3, Issue 1, 2015, Pages 16-21

  Koyama, Kohei ^a   Takahara, Kiyoshi ^a   Inamoto, Teruo ^a   Ibuki, Naokazu ^a   Minami, Koichiro ^a   Uehara, Hirofumi ^a   Komura, Kazumasa ^a   Nishida, Takeshi ^a   Sakamoto, Takeshi ^a   Hirano, Hajime ^a   Nomi, Hayahito ^a   Kiyama, Satoshi ^a   Azuma, Haruhito ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Castrate resistant disease; Prostate cancer

Indexed keywords

CIRCADIAN RHYTHM SIGNALING PROTEIN; COMPLEMENTARY DNA; E74 LIKE FACTOR 5; PERIOD CIRCADIAN PROTEIN HOMOLOG 1; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANDROGEN DEPRIVATION THERAPY; ARTICLE; CASTRATION RESISTANT PROSTATE CANCER; CELL GROWTH; CONTROLLED STUDY; CYTOSOL; GENE EXPRESSION; HORMONE SENSITIVITY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; IN VITRO STUDY; LNCAP CELL LINE; MALE; MICROARRAY ANALYSIS; MTT ASSAY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE CANCER CELL LINE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 84928236575     PISSN: 22878882     EISSN: 2287903X     Source Type: Journal    
DOI: 10.1016/j.prnil.2015.02.004     Document Type: Article

References (29)

1. M.F. Nunn, P.H. Seeburg, C. Moscovici, and P.H. Duesberg Tripartite structure of the avian erythroblastosis virus e26 transforming gene Nature 306 1983 391 395
2. P. Oettgen, K. Kas, and A. Dube et al. Characterization of ESE-2, a novel ESE-1-related Ets transcription factor that is restricted to glandular epithelium and differentiated keratinocytes J Biol Chem 274 1999 29439 29452
3. C.Y. Wang, B. Petryniak, I.C. Ho, C.B. Thompson, and J.M. Leiden Evolutionarily conserved ets family members display distinct DNA binding specificities J Exp Med 175 1992 1391 1399
4. B. Wasylyk, S.L. Hahn, and A. Giovane The Ets family of transcription factors Eur J Biochem 211 1993 7 18
5. Y.S. Choi, R. Chakrabarti, R. Escamilla-Hernandez, and S. Sinha Elf5 conditional knockout mice reveal its role as a master regulator in mammary alveolar development: failure of Stat5 activation and functional differentiation in the absence of Elf5 Dev Biol 329 2009 227 241
6. M. Donnison, A. Beaton, H.W. Davey, R. Broadhurst, P. L'Huillier, and P.L. Pfeffer Loss of the extraembryonic ectoderm in Elf5 mutants leads to defects in embryonic patterning Development 132 2005 2299 2308
7. C.J. Watson, and W.T. Khaled Mammary development in the embryo and adult: a journey of morphogenesis and commitment Development 135 2008 995 1003
8. N.K. Bhat, C.B. Thompson, and T. Lindsten et al. Reciprocal expression of human ETS1 and ETS2 genes during T-cell activation: regulatory role for the protooncogene ETS1 Proc Natl Acad Sci U S A 87 1990 3723 3727
9. I. Kola, S. Brookes, and A.R. Green et al. The Ets1 transcription factor is widely expressed during murine embryo development and is associated with mesodermal cells involved in morphogenetic processes such as organ formation Proc Natl Acad Sci U S A 90 1993 7588 7592
10. B.X. Xie, H. Zhang, and J. Wang et al. Analysis of differentially expressed genes in LNCaP prostate cancer progression model J Androl 32 2011 170 182
11. P. Oettgen, E. Finger, and Z. Sun et al. PDEF, a novel prostate epithelium-specific ets transcription factor, interacts with the androgen receptor and activates prostate-specific antigen gene expression J Biol Chem 275 2000 1216 1225
12. A. Ghadersohi, S. Sharma, and S. Zhang et al. Prostate-derived Ets transcription factor (PDEF) is a potential prognostic marker in patients with prostate cancer Prostate 71 2011 1178 1188
13. D.P. Turner, V.J. Findlay, and O. Moussa et al. Mechanisms and functional consequences of PDEF protein expression loss during prostate cancer progression Prostate 71 2011 1723 1735
14. A.K. Sood, R. Saxena, and J. Groth et al. Expression characteristics of prostate-derived ets factor support a role in breast and prostate cancer progression Hum Pathol 38 2007 1628 1638
15. S. Ngan, E.A. Stronach, A. Photiou, J. Waxman, S. Ali, and L. Buluwela Microarray coupled to quantitative RT-PCR analysis of androgen-regulated genes in human LNCaP prostate cancer cells Oncogene 28 2009 2051 2063
16. S. Shah, and E. Small Emerging biological observations in prostate cancer Expert Rev Anticancer Ther 10 2010 89 101
17. H.J. Lee, and C.J. Ormandy Elf5, hormones and cell fate Trends Endocrinol Metab 23 2012 292 298
18. A. Gutierrez-Hartmann, D.L. Duval, and A.P. Bradford Ets transcription factors in endocrine systems Trends Endocrinol Metab 18 2007 150 158
19. E.J. Lapinskas, J. Palmer, S. Ricardo, P.J. Hertzog, A. Hammacher, and M.A. Pritchard A major site of expression of the Ets transcription factor Elf5 is epithelia of exocrine glands Histochem Cell Biol 122 2004 521 526
20. J. Zhou, A.Y. Ng, and M.J. Tymms et al. A novel transcription factor, ELF5, belongs to the ELF subfamily of ETS genes and maps to human chromosome 11p13-15, a region subject to LOH and rearrangement in human carcinoma cell lines Oncogene 17 1998 2719 2732
21. Z.S. Sun, U. Albrecht, O. Zhuchenko, J. Bailey, G. Eichele, and C.C. Lee Rigui, a putative mammalian ortholog of the Drosophila period gene Cell 90 1997 1003 1011
22. C.H. Ko, and J.S. Takahashi Molecular components of the mammalian circadian clock Hum Mol Genet 15 Spec No 2 2006 R271 R277
23. S.M. Reppert, and D.R. Weaver Coordination of circadian timing in mammals Nature 418 2002 935 941
24. U. Schibler, and P. Sassone-Corsi A web of circadian pacemakers Cell 111 2002 919 922
25. L.P. Shearman, S. Sriram, and D.R. Weaver et al. Interacting molecular loops in the mammalian circadian clock Science 288 2000 1013 1019
26. L. Fu, H. Pelicano, J. Liu, P. Huang, and C. Lee The circadian gene period2 plays an important role in tumor suppression and DNA damage response in vivo Cell 111 2002 41 50
27. T. Matsuo, S. Yamaguchi, S. Mitsui, A. Emi, F. Shimoda, and H. Okamura Control mechanism of the circadian clock for timing of cell division in vivo Science 302 2003 255 259
28. L. Fu, and C.C. Lee The circadian clock: pacemaker and tumour suppressor Nat Rev Cancer 3 2003 350 361
29. Q. Cao, S. Gery, and A. Dashti et al. A role for the clock gene per1 in prostate cancer Cancer Res 69 2009 7619 7625